Analyst Price Target is $32.07
▼ -51.02% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Surgery Partners in the last 3 months. The average price target is $32.07, with a high forecast of $61.00 and a low forecast of $17.50. The average price target represents a -51.02% upside from the last price of $65.48.
Current Consensus is
The current consensus among 8 investment analysts is to buy stock in Surgery Partners. This rating has held steady since December 2019, when it changed from a Hold consensus rating.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2020, it owned or operated a portfolio of 127 surgical facilities, including 110 ambulatory surgical centers and 17 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.